New York 2025-2026 Regular Session

New York Senate Bill S08545

Introduced
10/24/25  
Refer
10/24/25  
Refer
1/7/26  

Caption

Requires that newborns are tested for Gaucher disease.

Impact

The implementation of S08545 would result in significant changes to current public health practices regarding newborn screening. By adding Gaucher disease to the list of conditions for which newborns must be screened, the state of New York raises awareness about the importance of early detection of genetic disorders. Healthcare providers will need to adjust their protocols and ensure that appropriate tests are conducted effectively at birth, which may require additional training and resources within the healthcare system.

Summary

Bill S08545, introduced in the New York Senate, mandates that all newborns in the state undergo screening for Gaucher disease as part of their routine health assessments. Gaucher disease is a rare genetic disorder that can lead to serious health complications if not diagnosed and treated early. The bill aims to enhance early detection and intervention for infants affected by this condition, ultimately improving health outcomes and reducing long-term healthcare costs associated with untreated cases.

Contention

While the bill is largely supported due to its potential public health benefits, there may be concerns regarding the costs associated with implementing widespread newborn screening for Gaucher disease. Opponents might argue that such mandates could place a financial burden on healthcare providers and the state's public health system. Additionally, discussions could arise surrounding the accuracy of screenings, potential false positives, and the psychological implications for parents of affected infants.

Notable_points

S08545 reflects a growing trend in public health legislation aiming to address rare genetic diseases through early intervention strategies. The bill highlights the importance of preventive care within public health policy and underscores the need for a comprehensive approach to genetic disorders. Additionally, it serves as a reminder of the ongoing dialogue between healthcare access, cost management, and improved health outcomes for vulnerable populations.

Companion Bills

NY A09211

Same As Requires that newborns are tested for Gaucher disease.

Previously Filed As

NY A09211

Requires that newborns are tested for Gaucher disease.

NY HB1055

Health - Newborn Screening Program - Gaucher Disease

NY SB495

Health - Newborn Screening Program - Gaucher Disease

NY A10521

Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state; requires tests be made available within twelve months.

NY S09659

Requires health insurance coverage for home test kits for sexually transmitted diseases.

NY A10873

Requires insurance coverage for peripheral artery disease.

NY HB1055

Health - Newborn Screening Program - Gaucher Disease

NY S06862

Requires health insurers to provide coverage for long term medical care for Lyme disease and other tick borne related pathogens.

NY S10132

Provides for a performance and discharge of duty presumption for diseases of the lung of Nassau county fire marshals.

NY S08487

Establishes a Legionnaires' disease awareness and education program on the symptoms, diagnosis and treatment of Legionnaires' disease.

Similar Bills

No similar bills found.